Abstract :

MPOX (formerly known as monkeypox) has emerged as a significant public health concern in recent years, necessitating a comprehensive understanding of its epidemiology, clinical manifestations, treatment options, prevention strategies, and global health impact. This literature review synthesizes the latest data on the spread and incidence of MPOX, with a focus on geographic distribution, affected populations, and emerging trends in transmission. The clinical presentation of MPOX, including symptoms, disease progression, and complications, is explored, with particular attention to variations across different demographics. Recent advances in the treatment of MPOX are analyzed, covering current antiviral therapies, the role of supportive care, and the potential of new treatments under investigation. Prevention strategies are also examined, highlighting the effectiveness of vaccination efforts, public health measures, and containment and control strategies. The review further considers the broader impact of MPOX on global health, discussing its implications for public health policy and pandemic preparedness. Through this comprehensive analysis, the review aims to provide a robust foundation for understanding MPOX and inform future research, clinical practice, and public health initiatives.

---

Keywords :

Clinical Manifestations, Epidemiology, MPOX (Monkeypox), Orthopoxvirus, Prevention strategies, Treatment Advances.

---

References :

1. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. The Lancet. 2023 Jan 7;401(10370):60-74.
2. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V. Monkeypox virus infection in humans across 16 countries—April–June 2022. New England Journal of Medicine. 2022 Aug 25;387(8):679-91.
3. Laurenson-Schafer H, Sklenovská N, Hoxha A, Kerr SM, Ndumbi P, Fitzner J, Almiron M, de Sousa LA, Briand S, Cenciarelli O, Colombe S. Description of the first global outbreak of mpox: an analysis of global surveillance data. The Lancet Global Health. 2023 Jul 1;11(7):e1012-23.
4. Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy. 2022 Nov 2;7(1):1-22.
5. Gao L, Shi Q, Dong X, Wang M, Liu Z, Li Z. Mpox, Caused by the MPXV of the Clade IIb lineage, goes global. Tropical Medicine and Infectious Disease. 2023 Jan 20;8(2):76.
6. Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA. Monkeypox: A contemporary review for healthcare professionals. Open Forum Infect Dis. 2022;9(7):ofac310.
7. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022;387(8):679-91.
8. Nishiura H, Yuan B, Endo A. Estimating the transmission advantage of monkeypox virus versus human smallpox virus in the contemporary 2022 outbreak. medRxiv. 2022:2022.06.13.22276353.
9. Reynolds MG, Davidson WB, Curns AT, Conover CS, Huhn G, Davis JP, et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis. 2007;13(9):1332.
10. Adalja A, Inglesby T. A Novel International Monkeypox Outbreak. Ann Intern Med. 2022;175(8):1175-1176.
11. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.
12. World Health Organization. Monkeypox [Internet]. 2022 [cited 2023 May 28]. Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox
13. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156(2):293-298.
14. Petersen E, Kantele A, Koopmans M, et al. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019;33(4):1027-1043.
15. Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011;29 Suppl 4:D54-D59.
16. Minhaj FS, Ogale YP, Whitehill F, et al. Monkeypox Outbreak – Nine States, May 2022. MMWR Morb Mortal Wkly Rep. 2022;71(23):764-769.
17. Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153-1162.
18. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86(Pt 10):2661-2672.
19. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus Infection in Humans across 16 Countries – April-June 2022. N Engl J Med. 2022;387(8):679-691.
20. Perez Duque M, Ribeiro S, Martins JV, et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill. 2022;27(22):2200424.
21. Mughal Z, Simpson CR, Fairley K, Kerr M, Peyramaure A, McKnight JA. The potential role of oral tecovirimat in the treatment of human monkeypox infection. Int J Infect Dis. 2023;125:92-94.
22. Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(22):734-742.
23. Contag CH, Li X, Zeng W, Jing L, Yang J, Wang J, et al. Evolving phenotypes and tropism in current and future monkeypox outbreaks. Front Microbiol. 2023;14:1121815.
24. Siegrist E, Sassine M. The re-emergence of human monkeypox virus. Virologie (Montrouge). 2022;26(4):209-220.
25. Miao Q, Zheng L, Ling Y, Liu J, Zeng Y. Evaluation of the efficacy of modified vaccinia Ankara vaccine or cidofovir treatment in mouse models of lethal orthopoxvirus infection. Antiviral Res. 2018;153:70-77.
26. Millan‐Billi P, Fernandez I, Doval A, Aldanondo I, Lopez-Varas L, Ubals M, et al. Cross-sectional study of monkeypox cases reported from May to July 2022 in Barcelona, Spain. J Eur Acad Dermatol Venereol. 2022;36(12):e950-e952.
27. Parker S, Nuara A, Buller RM, Schultz DA. Human monkeypox: an emerging zoonotic disease. Future Microbiol. 2007;2(1):17-34.
28. Chakraborty C, Bhattacharya M, Sharma AR. Emerging mutations in monkeypox virus: Should we be concerned?. Int J Surg. 2022;104:106867.
29. Филиппов ДВ, Чикин ВВ, Караулов АВ. Monkeypox virus. Иммунология. 2023;44(1):72-78.
30. Clinical Considerations for Treatment and Prophylaxis of Mpox Infection in People Who are Immunocompromised. Ann Intern Med. 2023. doi:10.7326/M23-0979.
31. Elshabrawy HA, Coughlin MM, Baker SC, Prabhakar BS. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One. 2012;7(11):e50366.
32. Bhattacharjee A, Halder A, Maity S, Bandyopadhyay B, Dutta A. Mutational spectra analysis of SARS-CoV-2 variants shows an intrinsic evolutionary tendency towards immune-escape. Comput Struct Biotechnol J. 2021;19:4808-4815.
33. Sadeuh‐Mba SA, Yonga MG, Els M, Batejat C, Eyangoh S, Caro V, et al. Monkeypox virus phylogenetic similarities between a human case detected in Cameroon in 2018 and the 2017–2018 outbreak in Nigeria. Infect Genet Evol. 2019;69:8-11.
34. Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(22):734-742.
35. Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, et al. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox. N Engl J Med. 2019;381(20):1897-1908.
36. Nguyen PY, Ajisegiri WS, Costantino V, Chughtai AA, MacIntyre CR. Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020. Emerg Infect Dis. 2021;27(4):1007-1014.
37. Kucharski AJ, Flasche S, Lowe R. Effectiveness of contact tracing for containment of monkeypox transmission. The Lancet. 2020;395(10238):1541-1542.
38. Beer K, Bhargavi M. Global human monkeypox outbreak: atypical presentation demanding urgent public health action. The Lancet. 2022;400(10353):749.
39. Durski KN, McCollum AM, Nakazawa Y, Petersen BW, Reynolds MG, Briand S, et al. Emergence of Monkeypox – West and Central Africa, 1970-2017. MMWR Morb Mortal Wkly Rep. 2018;67(10):306-310.
40. Minka EC, Verma A, Doty JB, Baharith T, Boubacar NA, Keita S, et al. Monkeypox outbreak preparedness and response in the WHO African region. The Lancet. 2022;400(10357):986-988.
41. Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19(8):872-879.
42. Chams N, Chams S, Badran R, Shams A, Araji A, Raad M, et al. COVID-19: A Multidisciplinary Review. Front Public Health. 2020;8:383.
43. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. World Health Organization: Geneva. 1988.
44. Polonsky JA, Baidjoe A, Kamvar ZN, Cori A, Durski K, Edmunds WJ, et al. Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philos Trans R Soc Lond B Biol Sci. 2019;374(1776):20180276.
45. Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature. 2022;606(7916):820-821.
46. World Health Organization. Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022. World Health Organization; 2022.
47. Rao AK, Schulte J, Chen TH, Hughes CM, Davidson W, Neff JM, et al. Monkeypox in a Traveler Returning from Nigeria – Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep. 2022;71(14):509-516.
48. Bartsch SM, Asti L, Cox SN, Durham DP, Randall S, Hotez PJ, et al. What is the Value of Different Zoonotic Disease Surveillance Targets? Analysis of a 2018 Monkeypox Case. Clin Infect Dis. 2021;73(2):352-359.
49. Nuzzo JB, Borio LL, Gostin LO. The WHO Declaration of Monkeypox as a Global Public Health Emergency. JAMA. 2022;328(7):615-617.
50. Makhashvili N, Javakhishvili M, Sturua L, Pilauri K, Fuhr DC, Roberts B. The influence of concern about COVID-19 on mental health in the Republic of Georgia: a cross-sectional study. Glob Health. 2020;16(1):111.
51. Adalja AA, Toner E, Inglesby TV. Priorities for the US Health Community Responding to COVID-19. JAMA. 2020;323(14):1343-1344.
52. Kluge HHP, Wickramasinghe K, Rippin HL, Mendes R, Peters DH, Kontsevaya A, et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. 2020;395(10238):1678-1680.
53. Bedford J, Farrar J, Ihekweazu C, Kang G, Koopmans M, Nkengasong J. A new twenty-first century science for effective epidemic response. Nature. 2019;575(7781):130-136.
54. Saalim K, Sakyi KS, Fatema-Tuz-Zohra, Morrison E, Owusu P, Dalglish SL, et al. Reported health and social consequences of the COVID-19 pandemic on vulnerable populations and implemented solutions in six West African countries: A media content analysis. PLOS ONE. 2021;16(6):e0252890.
55. Gilmore B, Ndejjo R, Tchetchia A, de Claro V, Mago E, Diallo AA, et al. Community engagement for COVID-19 prevention and control: A rapid evidence synthesis. BMJ Glob Health. 2020;5(10):e003188.
56. Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, et al. Monkeypox – Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019;78:78-84.
57. Witkowski PT, Adamczyk T, Nitsche A. Monkeypox virus: where are we and where are we going? Virus Res. 2023;325:198998.
58. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260-7.
59. Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA. Monkeypox: A Contemporary Review for Healthcare Professionals. Open Forum Infect Dis. 2022;9(7):ofac310.
60. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153-62.
61. Girometti N, Byrne R, Bracchi M, Heskin J, McOwan A, Tittle V, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022;22(9):1321-8.
62. Nuzzo JB, Borio LL, Gostin LO. The WHO declaration of monkeypox as a global public health emergency. JAMA. 2022;328(7):615-7.
63. Tian H, Li Y, Shao J, Su X, Yin C. Novel antiviral strategies for human monkeypox virus infection. Front Microbiol. 2022;13:1016480.